Literature DB >> 17720027

Schizophrenia: measurements of psychopathology.

J P Lindenmayer1, Philip D Harvey, Anzalee Khan, Brian Kirkpatrick.   

Abstract

A key problem in schizophrenia research is how to assess the effects of treatment interventions given the spectrum of schizophrenia symptoms and patients' functioning. Measuring symptoms is complex, because these symptoms cover a wide variety of psychopathologic domains. The commonly recognized domains are the positive, negative, cognitive, excitement, and depression domains. This article critically reviews some of the available assessment tools of these domains together with other associated syndromes. The instruments discussed cover the broad range of psychopathology found in patients who have schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17720027     DOI: 10.1016/j.psc.2007.04.005

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  8 in total

1.  Altered Coupling Between Resting-State Cerebral Blood Flow and Functional Connectivity in Schizophrenia.

Authors:  Jiajia Zhu; Chuanjun Zhuo; Lixue Xu; Feng Liu; Wen Qin; Chunshui Yu
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

2.  Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration.

Authors:  Mathangi Gopalakrishnan; Tiffany Farchione; Mitchell Mathis; Hao Zhu; Mehul Mehta; Ramana Uppoor; Islam Younis
Journal:  Psychiatr Res Clin Pract       Date:  2020-11-06

3.  Serum BDNF Is Positively Associated With Negative Symptoms in Older Adults With Schizophrenia.

Authors:  Sasha S Binford; Erin M Hubbard; Elena Flowers; Bruce L Miller; Heather Leutwyler
Journal:  Biol Res Nurs       Date:  2017-10-19       Impact factor: 2.522

4.  Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophrenia.

Authors:  H Leutwyler; E Hubbard; D Jeste; B Miller; S Vinogradov
Journal:  Aging Ment Health       Date:  2014-04-04       Impact factor: 3.658

5.  Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysis.

Authors:  Jitsuki Sawamura; Shigeru Morishita; Jun Ishigooka
Journal:  BMC Psychiatry       Date:  2010-12-07       Impact factor: 3.630

6.  Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Anzalee Khan; Charles Lewis; Jean-Pierre Lindenmayer
Journal:  BMC Psychiatry       Date:  2011-11-16       Impact factor: 3.630

7.  Factor structure of the targeted inventory on problems in schizophrenia.

Authors:  Shoji Tanaka; Takanori Nagase; Takefumi Suzuki; Kensuke Nomura; Hiroyoshi Takeuchi; Shinichiro Nakajima; Hiroyuki Uchida; Gohei Yagi; Koichiro Watanabe; Masaru Mimura
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-04-24       Impact factor: 2.582

8.  The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms.

Authors:  Christine Wyss; Konrad Hitz; Michael P Hengartner; Anastasia Theodoridou; Caitriona Obermann; Idun Uhl; Patrik Roser; Edna Grünblatt; Erich Seifritz; Georg Juckel; Wolfram Kawohl
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.